ORIGINAL
Prevalencia de contraindicaciones a succinilcolina en unidades de cuidados intensivos
Contraindications to succinylcholine in the intensive care unit. A prevalence study
T. Muñoz-Martínez
, I. Garrido-Santos, R. Arévalo-Cerón, L. Rojas-Viguera, T. Cantera-Fernández, R. Pérez-González, E. Díaz-Garmendia
Servicio de Medicina Intensiva, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España
Leído
57366
Vecesse ha leído el artículo
8874
Total PDF
48492
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 64 | 10 | 74 |
| 2025 10 | 36 | 94 | 130 |
| 2025 9 | 0 | 82 | 82 |
| 2025 8 | 0 | 113 | 113 |
| 2025 7 | 0 | 67 | 67 |
| 2025 6 | 14 | 67 | 81 |
| 2025 5 | 672 | 116 | 788 |
| 2025 4 | 556 | 93 | 649 |
| 2025 3 | 702 | 94 | 796 |
| 2025 2 | 965 | 107 | 1072 |
| 2025 1 | 576 | 99 | 675 |
| 2024 12 | 503 | 146 | 649 |
| 2024 11 | 538 | 141 | 679 |
| 2024 10 | 709 | 185 | 894 |
| 2024 9 | 979 | 143 | 1122 |
| 2024 8 | 754 | 121 | 875 |
| 2024 7 | 713 | 93 | 806 |
| 2024 6 | 615 | 130 | 745 |
| 2024 5 | 687 | 119 | 806 |
| 2024 4 | 700 | 105 | 805 |
| 2024 3 | 645 | 103 | 748 |
| 2024 2 | 611 | 129 | 740 |
| 2024 1 | 578 | 162 | 740 |
| 2023 12 | 535 | 290 | 825 |
| 2023 11 | 724 | 225 | 949 |
| 2023 10 | 941 | 109 | 1050 |
| 2023 9 | 916 | 76 | 992 |
| 2023 8 | 797 | 43 | 840 |
| 2023 7 | 410 | 38 | 448 |
| 2023 6 | 382 | 29 | 411 |
| 2023 5 | 576 | 53 | 629 |
| 2023 4 | 544 | 52 | 596 |
| 2023 3 | 621 | 85 | 706 |
| 2023 2 | 582 | 86 | 668 |
| 2022 1 | 372 | 85 | 457 |
| 2022 12 | 297 | 79 | 376 |
| 2022 11 | 657 | 68 | 725 |
| 2022 10 | 600 | 57 | 657 |
| 2022 9 | 788 | 66 | 854 |
| 2022 8 | 589 | 53 | 642 |
| 2022 7 | 407 | 59 | 466 |
| 2022 6 | 348 | 57 | 405 |
| 2022 5 | 470 | 74 | 544 |
| 2022 4 | 452 | 56 | 508 |
| 2022 3 | 449 | 97 | 546 |
| 2022 2 | 402 | 62 | 464 |
| 2021 1 | 348 | 63 | 411 |
| 2021 12 | 384 | 71 | 455 |
| 2021 11 | 495 | 75 | 570 |
| 2021 10 | 552 | 101 | 653 |
| 2021 9 | 416 | 91 | 507 |
| 2021 8 | 469 | 122 | 591 |
| 2021 7 | 432 | 90 | 522 |
| 2021 6 | 489 | 84 | 573 |
| 2021 5 | 453 | 100 | 553 |
| 2021 4 | 1002 | 151 | 1153 |
| 2021 3 | 676 | 86 | 762 |
| 2021 2 | 574 | 74 | 648 |
| 2020 1 | 470 | 34 | 504 |
| 2020 12 | 462 | 33 | 495 |
| 2020 11 | 467 | 51 | 518 |
| 2020 10 | 393 | 41 | 434 |
| 2020 9 | 467 | 40 | 507 |
| 2020 8 | 418 | 45 | 463 |
| 2020 7 | 433 | 38 | 471 |
| 2020 6 | 390 | 52 | 442 |
| 2020 5 | 500 | 49 | 549 |
| 2020 4 | 667 | 65 | 732 |
| 2020 3 | 349 | 41 | 390 |
| 2020 2 | 612 | 86 | 698 |
| 2020 1 | 442 | 49 | 491 |
| 2019 12 | 671 | 59 | 730 |
| 2019 11 | 690 | 72 | 762 |
| 2019 10 | 1452 | 105 | 1557 |
| 2019 9 | 743 | 115 | 858 |
| 2019 8 | 513 | 99 | 612 |
| 2019 7 | 511 | 82 | 593 |
| 2019 6 | 397 | 65 | 462 |
| 2019 5 | 481 | 94 | 575 |
| 2019 4 | 462 | 125 | 587 |
| 2019 3 | 291 | 100 | 391 |
| 2019 2 | 228 | 124 | 352 |
| 2019 1 | 212 | 96 | 308 |
| 2018 12 | 280 | 129 | 409 |
| 2018 11 | 401 | 159 | 560 |
| 2018 10 | 264 | 73 | 337 |
| 2018 9 | 447 | 52 | 499 |
| 2018 8 | 237 | 46 | 283 |
| 2018 7 | 86 | 47 | 133 |
| 2018 6 | 124 | 39 | 163 |
| 2018 5 | 46 | 26 | 72 |
| 2018 4 | 106 | 61 | 167 |
| 2018 3 | 83 | 37 | 120 |
| 2018 2 | 84 | 36 | 120 |
| 2018 1 | 121 | 50 | 171 |
| 2017 12 | 62 | 23 | 85 |
| 2017 11 | 134 | 31 | 165 |
| 2017 10 | 144 | 41 | 185 |
| 2017 9 | 105 | 43 | 148 |
| 2017 8 | 69 | 43 | 112 |
| 2017 7 | 1030 | 27 | 1057 |
| 2017 6 | 58 | 65 | 123 |
| 2017 5 | 75 | 52 | 127 |
| 2017 4 | 92 | 60 | 152 |
| 2017 3 | 95 | 64 | 159 |
| 2017 2 | 188 | 50 | 238 |
| 2016 1 | 83 | 38 | 121 |
| 2016 12 | 60 | 43 | 103 |
| 2016 11 | 118 | 71 | 189 |
| 2016 10 | 120 | 58 | 178 |
| 2016 9 | 135 | 58 | 193 |
| 2016 8 | 104 | 35 | 139 |
| 2016 7 | 54 | 31 | 85 |
Mostrar todo
